Human CD83 PE-conjugated Antibody Summary
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of CD83 in CD14+ Monocyte-derived Dendritic Cells by Flow Cytometry. CD14+ monocyte-derived dendritic cells were stained with Mouse Anti-Human CD83 PE-conjugated Monoclonal Antibody (Catalog # FAB1774P, filled histogram) or isotype control antibody (IC002P, open histogram). View our protocol for Staining Membrane-associated Proteins.
Detection of CD83 in Daudi cells by Flow Cytometry. Daudi cells were stained with Mouse Anti-Human CD83 PE‑conjugated Monoclonal Antibody (Catalog # FAB1774P, filled histogram) or isotype control antibody (Catalog # IC002P, open histogram). View our protocol for Staining Membrane-associated Proteins.
Reconstitution Calculator
Preparation and Storage
Background: CD83
Human CD83 is a 40‑50 kDa member of the Siglec (or Sialic-acid-binding Immunoglobulin-like Lectin) family of transmembrane proteins (1, 2, 3). CD83 is synthesized as a type I transmembrane glycoprotein that contains a 125 amino acid (aa) extracellular region, a 22 aa transmembrane segment, and 39 aa cytoplasmic domain. It contains one V type Ig-like domain in the extracellular region with no inhibitory cytoplasmic motif(s). Although in vitro studies suggest CD83 may form membrane-bound covalent homodimers, in vivo this does not appear to be the case (1, 4). In the extracellular region, mouse and human CD83 are 66% aa identical (1, 2, 4, 5). Relative to human, mouse CD83 is 11 aa shorter in its extracellular domain and is expressed as a 30‑35 kDa protein (1, 4, 5). Human CD83 is active in the mouse system (4). One alternate splice form has been reported. This leads to a small monomeric soluble form of 74 aa that includes aa 20‑52 and aa 164‑205 (6, 7). In human, proteolytic cleavage and solubilization of CD83 has also been suggested, and this could lead to dimeric circulating CD83 (4, 6). CD83 is a primary marker for dendritic cells (3, 6, 8). It is also found on B cells (6, 9), neutrophils (10), monocytes and macrophages (11). Except for dendritic cells, CD83 expression is often transient. CD83 binds to sialic acids on target cells (12). Membrane CD83 appears to promote T cell proliferation, particularly of CD8+ cytotoxic T cells (13, 14). Soluble CD83, however, appears to be immunosuppressive and blocks T cell activation (15, 16). On monocytes, CD83 is suggested to drive monocytes into a fibrocyte phenotype (13). A lack of membrane-expressed CD83 leads to an unusual IL-4/IL-10 producing CD4+ T cell phenotype (17).
- Zhou, L-J. et al. (1992) J. Immunol. 149:735.
- Kozlow, E.J. et al. (1993) Blood 81:454.
- Fujimoto, Y and T.F. Tedder (2006) J. Med. Dent. Sci. 53:85.
- Lechmann, M. et al. (2005) Biochem. Biophys. Res. Commun. 329:132.
- Berchtold, S. et. al. (1999) FEBS Lett. 461:211.
- Hock, B.D. et al. (2001) Int. Immunol. 13:959.
- Dudziak, D. et al. (2005) J. Immunol. 174:6672.
- Velten, F.W. et al. (2007) Mol. Immunol. 44:1544.
- Cramer, S.O. et al. (2000) Int. Immunol. 12:1347.
- Yamashiro, S. et al. (2000) Blood 96:3958.
- Cao, W. et al. (2005) Biochem. J. 385:85.
- Scholler, N. et al. (2001) J. Immunol. 166:3865.
- Scholler, N. et al. (2002) J. Immunol. 168:2599.
- Hirano, N. et al. (2006) Blood 107:1528.
- Kotzor, N. et al. (2004) Immunobiology 209:129.
- Zinser, E. et al. (2006) Immunobiology 211:449.
- Garcia-Martinez, L.F. et al. (2004) J. Immunol. 173:2995.
Product Datasheets
Citations for Human CD83 PE-conjugated Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
4
Citations: Showing 1 - 4
Filter your results:
Filter by:
-
A novel potential effective strategy for enhancing the antitumor immune response in breast cancer patients using a viable cancer cell‑dendritic cell‑based vaccine
Authors: Mona S Abdellateif, Sabry M Shaarawy, Eman Z Kandeel, Ahmed H El‑Habashy, Mohamed L Salem, Motawa E El‑Houseini
Oncology Letters
-
Defective Regulation of Membrane TNF&alpha Expression in Dendritic Cells of Glioblastoma Patients Leads to the Impairment of Cytotoxic Activity against Autologous Tumor Cells
Authors: T Tyrinova, O Leplina, S Mishinov, M Tikhonova, E Dolgova, A Proskurina, V Stupack, S Bogachev, A Ostanin, E Chernykh
Int J Mol Sci, 2020-04-21;21(8):.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Oxidation of ovarian epithelial cancer cells by hypochlorous acid enhances immunogenicity and stimulates T cells that recognize autologous primary tumor.
Authors: Chiang CL, Ledermann JA, Aitkens E, Benjamin E, Katz DR, Chain BM
Clin. Cancer Res., 2008-08-01;14(15):4898-907.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Eosinophils induce DC maturation, regulating immunity.
Authors: Lotfi R, Lotze MT
J. Leukoc. Biol., 2007-11-08;83(3):456-60.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human CD83 PE-conjugated Antibody
There are currently no reviews for this product. Be the first to review Human CD83 PE-conjugated Antibody and earn rewards!
Have you used Human CD83 PE-conjugated Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image